Rivaroxaban vs Upadacitinib

## Rivaroxaban vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Rivaroxaban** and **Upadacitinib**.

## Mechanism of Action

**Rivaroxaban**: Direct Factor Xa inhibitor.

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Rivaroxaban — 5-9 hours; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Rivaroxaban — C19H18ClN3O5S; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Rivaroxaban — 435.8820 g/mol; Upadacitinib — 380.3700 g/mol.

**Type**: Rivaroxaban — Small molecule; Upadacitinib — Small molecule.